Member Info for Ghia

I wonder if this new short ace2 discovery removes any lingering safety concerns that the authorities have had.

If we are now viewed as a drug for all stages we may get a few surprises before P3 is finished.

The message was posted at 13.54 and made reference to a chat had this am and that they would post a note shortly.

So I can’t help I’m afraid.

Parsley - have I ever called you a deramper?

I ask questions just as you do.

You obviously have a nugget of information that you have found in the public domain that leads you to believe RM is in the USA.

Wouldn’t it be great if you chose to share that with the board rather than just attack all the time.

All the best with your investing.

Parsley - are you suggesting RM is visiting catalent? They do also have offices in the UK.

Millie - the original message on Advfn said that the call was this AM.

Nice to see you here gggg21 nova is a nice safe hold the longer this crisis continues. SNG is a giant payday for those who hold on long enough.

RM is working to extract the true value for shareholders. Traditionally shareholders would hold the board accountable for their performance on a 6monthly basis or even yearly.

It seems of late anything longer than a few weeks and it’s an outrage that we haven’t had an RNS. I can go longer at work without talking to my boss than 2weeks!!

If something deviates from plan for the better or worse that is share price sensitive we will be told, if you hear nothing it usually means things are going to plan give or take.

And lastly if you are so confident that this will sink because of vaccines go and put your money in a vaccine stock.

Tommy - please point me to information that shows tekvah have sold. The recent RNS was adjusting their previous holding based on the placing dilution. They still hold the same number of shares as far as I’m aware.

If you read the RNS information the company has put out it’s a no brainier to invest at these levels.

The Pi’s are nervous because they are mistrusting that things are on schedule.

A well connected ii will have a better feel for progress probably because there are conversations being had not necessarily revealing market sensitive info but you can definitely pick up tone from chats.

How useful are the RM or videos they never have market sensitive info beyond what has already been put in an RNS but they settle people’s nerves.

The two drugs today didn’t exactly have exciting success %’s

1 in 12 patients might benefit.

I think we should all be hoping Till’s performs better than this.

Gkb47 - the nebuliser is not the problem it’s simple the regulatory bodies think we are 310 people short of proving the safety and efficacy case via inhalation.

I suspect it is the safety case that is preventing the leap of faith EUA.

We are frustratingly close but quite rightly the regulators are doing their job.

Our time will come, I’m just thankful these desperately sick people are going to get something to assist them.

Gkb47 - I think you’ve answered your own question there because the delivery method has changed therefore there is no prior approval for SNG001.

There are inhaled MAB’s in the same boat.

It’s worth noting these where already approved drugs that are being repurposed ergo the decision process to give EUA is simple since stock is on the shelf and approval has already been granted focusing on another ailment.

It takes time for these large orders to be worked I wouldn’t be surprised if it’s actually a case of inpatient PI’s selling out, because news has not arrived as quickly as they have liked, creating the market for these large trades to execute.

The news that was always arriving then arrives shortly afterwards.

Some more new names on the list of Funds

https://www.morningstar.com/stocks/xlon/sng/ownership

Lack of news the company updated the market less than 3weeks ago!!

It wasn’t a TILs ramp I’m just not pinning my hopes on activ 2 quite yet.

I’d rather a big push to get P3 across the line.

I’m still unsure on activ 2 TILs have an inhaled MAB so reference to inhalation does not necessarily mean us.

Polar buying was the reason for the rise on Monday they crossed the threshold on the 4th.

Today’s drop is just supply and demand without the demand of Polar buying there was obviously more sellers in the market.

The phrase “go big or go home” definitely applies to Polar they are showing massive confidence here.

Is it written down anywhere or in a video that they will definitely RNS first patient doses?

I know they did it for P2 but I don’t think it’s the industry norm to do so.

I hope we get cracking ASAP the peak of cases seems to be aligning nicely with the trial.

Faye - it was large enough to get us a P3.